Cell Reports (Aug 2023)

Paired microbiome and metabolome analyses associate bile acid changes with colorectal cancer progression

  • Ting Fu,
  • Tao Huan,
  • Gibraan Rahman,
  • Hui Zhi,
  • Zhenjiang Xu,
  • Tae Gyu Oh,
  • Jian Guo,
  • Sally Coulter,
  • Anupriya Tripathi,
  • Cameron Martino,
  • Justin L. McCarville,
  • Qiyun Zhu,
  • Fritz Cayabyab,
  • Brian Low,
  • Mingxiao He,
  • Shipei Xing,
  • Fernando Vargas,
  • Ruth T. Yu,
  • Annette Atkins,
  • Christopher Liddle,
  • Janelle Ayres,
  • Manuela Raffatellu,
  • Pieter C. Dorrestein,
  • Michael Downes,
  • Rob Knight,
  • Ronald M. Evans

Journal volume & issue
Vol. 42, no. 8
p. 112997

Abstract

Read online

Summary: Colorectal cancer (CRC) is driven by genomic alterations in concert with dietary influences, with the gut microbiome implicated as an effector in disease development and progression. While meta-analyses have provided mechanistic insight into patients with CRC, study heterogeneity has limited causal associations. Using multi-omics studies on genetically controlled cohorts of mice, we identify diet as the major driver of microbial and metabolomic differences, with reductions in α diversity and widespread changes in cecal metabolites seen in high-fat diet (HFD)-fed mice. In addition, non-classic amino acid conjugation of the bile acid cholic acid (AA-CA) increased with HFD. We show that AA-CAs impact intestinal stem cell growth and demonstrate that Ileibacterium valens and Ruminococcus gnavus are able to synthesize these AA-CAs. This multi-omics dataset implicates diet-induced shifts in the microbiome and the metabolome in disease progression and has potential utility in future diagnostic and therapeutic developments.

Keywords